Stephen Kilmer | Investor Relations |
Tom Isett | Chairman and Chief Executive Officer |
Martin Brenner | Chief Scientific Officer |
Rob Lutz | Chief Financial and Business Officer |
Kristen Kluska | Cantor Fitzgerald |
Roy Buchanan | JMP Securities |
Matthew Herm | Matthew Herm LLC |
Philip Barnett | Private Investor |
Ladies and gentlemen, thank you for standing by and welcome to the iBio Fiscal 2022 Second Quarter Financial Results. [Operator Instructions] I would now like to turn the conference over to your speaker for today, Stephen Kilmer, Investor Relations.
You may begin.
Thank you. Good afternoon, everyone.